Publicações

Ras Inhibition and the Survival Benefit Favoring Zoledronic Acid Compared With Denosumab in Patients With Multiple Myeloma Reply

AuthID
P-002-Q77

Author(s)

Henry, DH

Scagliotti, GV

Spencer, A

Wang, JM

Jiang, Q

Jun, S

Dansey, R

Yeh, H

Tipo de Documento

Letter

Year published

2011

Publicado

in JOURNAL OF CLINICAL ONCOLOGY, ISSN: 0732-183X

Volume: 29, Número: 19, Páginas: 2736-2737 (3)

Indexing

Wos^®

Scopus^®

Google Scholar^®

Metadata
Fontes

Publication Identifiers

DOI: 10.1200/jco.2011.35.9182

SCOPUS: 2-s2.0-79960127725

Wos: WOS:000292210500035

Source Identifiers

ISSN: 0732-183X

Export Publication Metadata

Lista Marked

Adicionar à lista Marked

Info

At this moment we don't have any links to full text documens.

Ras Inhibition and the Survival Benefit Favoring Zoledronic Acid Compared With Denosumab in Patients With Multiple Myeloma Reply

Links Úteis

Ajuda

Autenticação Federada (Clique na imagem)

Ras Inhibition and the Survival Benefit Favoring Zoledronic Acid Compared With Denosumab in Patients With Multiple Myeloma Reply

Links Úteis

Ajuda